Cellectricon AB, a collaborative research organization dedicated to advancing drug discovery and research in the areas of chronic pain and CNS diseases, today announced the launch of a novel assay platform for in vitro neurodegenerative disease research. The platform, based on a patent-pending microfluidics technology, has been developed over the ... Read More...
Recent Posts
- Peru takes a Major Step on Legal Medical Cannabis February 23, 2019
- How the IT and Tech sector can stay ahead of digital change January 23, 2019
- The Genius benefits of an advertising agency January 23, 2019
- Top 20 of the UK’s Most Popular Tourist Attractions for 2018 announced January 22, 2019
- Plena Global Participating in Canada Cannabis House at Davos January 21, 2019
Submit Your Press Release at eNewsWire
eNewsWire is an online press release service offering both free and paid distribution. eNewWire distributes business, organisational and personal news and press releases using the Internet. Submit your press release here.